ARCOMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14 SEK | +2.19% |
|
+6.87% | +76.10% |
| Apr. 25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Jan. 29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 183M 16.88M | Sales 2025 * | 199M 18.35M | Capitalization | 185M 17.03M |
|---|---|---|---|---|---|
| Net income 2024 * | 14M 1.29M | Net income 2025 * | 16M 1.48M | EV / Sales 2024 * | 0.97 x |
| Net cash position 2024 * | 7M 646K | Net cash position 2025 * | 19M 1.75M | EV / Sales 2025 * | 0.83 x |
| P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
11.6
x | Employees | 31 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.16% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.19% | ||
| 1 week | +6.87% | ||
| Current month | +4.09% | ||
| 1 month | +21.74% | ||
| 3 months | +29.63% | ||
| 6 months | +79.49% | ||
| Current year | +76.10% |
1 week
12.90
14.15
1 month
11.2514.15
Current year
7.6014.15
1 year
6.3014.15
3 years
6.3021.20
5 years
6.3026.30
10 years
3.5726.30
| Managers | Title | Age | Since |
|---|---|---|---|
Johan Dahlberg
DFI | Director of Finance/CFO | 40 | 21-12-31 |
| Chief Tech/Sci/R&D Officer | 53 | 93-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 57 | 21-12-31 | |
| Director/Board Member | 53 | 10-02-28 | |
Lars Kvarnhem
CHM | Chairman | 52 | 16-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 14 | +2.19% | 31,669 |
| 24-05-08 | 13.7 | 0.00% | 18,815 |
| 24-05-07 | 13.7 | +1.48% | 13,220 |
| 24-05-06 | 13.5 | +3.05% | 47,791 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 11:06 am EDT
More quotes
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Calendar
2024-08-14
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +76.10% | 17.03M | |
| -4.01% | 14.91B | |
| -14.59% | 2.41B | |
| -11.01% | 1.48B | |
| -.--% | 1.12B | |
| +58.24% | 583M | |
| +94.87% | 515M | |
| +12.77% | 244M | |
| +0.12% | 230M | |
| +4.07% | 188M |
- Stock Market
- Equities
- ARCOMA Stock
